Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma

MLA

Hu, G., et al. “Targetable Fusions of the FRK Tyrosine Kinase in ALK-Negative Anaplastic Large Cell Lymphoma.” Leukemia, vol. 32, no. 2, Feb. 2018, pp. 565–69. EBSCOhost, https://doi.org/10.1038/leu.2017.309.

APA

Hu, G., Dasari, S., Asmann, Y. W., Greipp, P. T., Knudson, R. A., Benson, H. K., Li, Y., Eckloff, B. W., Jen, J., Link, B. K., Jiang, L., Sidhu, J. S., Wellik, L. E., Witzig, T. E., Bennani, N. N., Cerhan, J. R., Boddicker, R. L., & Feldman, A. L. (2018). Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma. Leukemia, 32(2), 565–569. https://doi.org/10.1038/leu.2017.309

Chicago

Hu, G, S Dasari, Y W Asmann, P T Greipp, R A Knudson, H K Benson, Y Li, et al. 2018. “Targetable Fusions of the FRK Tyrosine Kinase in ALK-Negative Anaplastic Large Cell Lymphoma.” Leukemia 32 (2): 565–69. doi:10.1038/leu.2017.309.